Alvotech (ALVO) Gross Margin (2022 - 2026)

Alvotech (ALVO) posted Gross Margin of 9.95% for Q1 2026, up 117.28% on a QoQ basis from 57.58% in Q4 2025, and down 3050.0% year-over-year from 0.34% in Q1 2025.

Alvotech (ALVO) Gross Margin (2022 - 2026) Analysis & Trends

Alvotech's Gross Margin history runs 5 years deep, the most recent figure standing at 9.95% for Q1 2026.

  • Quarterly Gross Margin fell 3050.0% year-over-year to 9.95% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62% (up 6226.0% YoY) and the FY2025 annual result came in at 14.74%, down 1750.0% from the prior year.
  • Gross Margin was 9.95% for Q1 2026 at Alvotech, up from 57.58% in the prior quarter.
  • Across five years, Gross Margin topped out at 40.45% in Q1 2025 and bottomed at 751.13% in Q4 2023.
  • A 5-year average of 154.43% and a median of 60.88% in 2024 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2023 — Gross Margin plunged 38587 bps — and 2024, when it soared 56999 bps.
  • Alvotech's Gross Margin stood at 365.27% in 2022, then plunged by 106 bps to 751.13% in 2023, then jumped by 76 bps to 181.15% in 2024, then soared by 68 bps to 57.58% in 2025, then surged by 117 bps to 9.95% in 2026.
  • Business Quant data shows ALVO's Gross Margin at 9.95% in Q1 2026, 57.58% in Q4 2025, and 7.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn 9.95%

Historic Data

Download Data
DateValue
Mar 31, 2026 9.95%
Dec 31, 2025 -57.58%
Sep 30, 2025 -7.22%
Jun 30, 2025 22.15%
Mar 31, 2025 40.45%
Dec 31, 2024 -181.15%
Sep 30, 2024 35.90%
Jun 30, 2024 -60.88%
Mar 31, 2024 -60.56%
Dec 31, 2023 -751.13%
Jun 30, 2023 -146.36%
Mar 31, 2023 -146.44%
Dec 31, 2022 -365.27%
Jun 30, 2022 -361.64%
Mar 31, 2022 -286.73%